Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
6.71M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
467K
-
Shares change
-
+222K
-
Total reported value, excl. options
-
$2M
-
Value change
-
+$1.08M
-
Number of buys
-
6
-
Number of sells
-
-7
-
Price
-
$4.29
Significant Holders of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) as of Q4 2024
24 filings reported holding VVOS - Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share as of Q4 2024.
Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 467K shares
of 6.71M outstanding shares and own 6.95% of the company stock.
Largest 10 shareholders include Anson Funds Management LP (243K shares), Strategic Wealth Investment Group, LLC (100K shares), GEODE CAPITAL MANAGEMENT, LLC (44.8K shares), Cutter & CO Brokerage, Inc. (38.1K shares), COMMONWEALTH EQUITY SERVICES, LLC (26K shares), VANGUARD GROUP INC (10.6K shares), Credit Agricole S A (2.37K shares), OSAIC HOLDINGS, INC. (593 shares), SIGNATUREFD, LLC (547 shares), and UBS Group AG (389 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.